DiaMedica Therapeutics Inc. (DMAC) Dropped -5.26% or -0.15 To Price $2.74 On Friday


DiaMedica Therapeutics Inc. (DMAC) dropped -5.26% or -0.15 to $2.74. It is close to 33501 shares traded, which is 94.41% compare to the average total volume 35484. The market cap of DMAC is $32.74 million. The year to date change is -15.79%. The 52 week price range is from $0.26 to $6.53. Price of DMAC have changed -1.03% during last week. It have changed -13.99% over last month, -13.73% over last 3 months, -42.20% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DMAC is 3.48. It is 27.01% above current price. The 200-day Moving Averages for DMAC is 2.49. It is -9.12% below current price. The 52-week High is 6.53. It is 138.32% from the current price. The 52-week Low is 0.26. It is -90.51% from current price.

There are some statistics of DMAC. It is has market cap $32.74 million. The share outstanding is 11.96 million. The average volume is 35484. The percent of top 15 Institution holding is 9.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DMAC is -91.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DMAC is -73.48%.


Tags:

Share this post